Skip to content

A Mass Balance Study of [14C]-IPN60250 in Healthy Adult Participants

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-515195-12-00
Acronym
CLIN-60250-451
Enrollment
7
Registered
2025-01-29
Start date
2025-02-18
Completion date
2025-04-14
Last updated
2025-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary sclerosing cholangitis (PSC)

Interventions

None listed

Sponsors

Ipsen Pharma
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026